Our People

The IMPACT Network is overseen by a Steering Committee which reports directly to the PSANZ Board through its Chair.

IMPACT Network Steering Committee

The Steering Committee membership is elected, according to committee membership criteria, by secret ballot from within the IMPACT Network membership following a call for nominations from the PSANZ membership. All nominations for this committee must be financial PSANZ members with relevant skills and experience in clinical trials and must be proposed and seconded by two PSANZ members.

Membership of the Steering Committee aims to ensure disciplinary and geographic representation. Representation from each of the following groups/disciplines is desired: consumers; midwifery; neonatology; neonatal nursing; obstetrics; obstetric medicine; maternal fetal medicine; scientists; trial co-ordinators; epidemiology and biostatistics.

Steering Committee members are elected for a term of three years, and members can be re-elected for a term not exceeding 6 consecutive years. The Committee will be led by a Chairperson elected by the Committee members.

Steering Committee Terms of Reference:

  • Overseeing the activities of the IMPACT Network; ensuring alignment with the Strategic Plan and its objectives
  • Revising the IMPACT Network Strategic Plan every 5 years or earlier as required
  • Ensuring financial viability of the IMPACT Network
  • Establishing and maintaining international links with the Cochrane Collaboration, other clinical trials networks and organisations or bodies
  • Assisting clinical colleges and other professional societies bring research evidence into clinical practice by promoting evidence-based care
  • Providing educational opportunities in critical appraisal and trial design
  • Establishing subcommittees and/or working parties of the IMPACT Network Committee as required to implement the Strategic Plan
  • Reporting to the PSANZ Board through the Committee Chair according to PSANZ Policy on: trial publication to PSANZ for dissemination to members, trials seeking additional collaborating centres for distribution across the PSANZ membership

IMPACT Network Steering Committee Members

  • katie groom


    Dr Katie Groom

    Dr Katie Groom is a Senior Lecturer in the Department of Obstetrics and Gynaecology, University of Auckland and Subspecialist in Maternal Fetal Medicine at National Women’s Health, Auckland City Hospital. Her research focuses on clinical trials of therapies and interventions for the prevention and treatment of the major complications of pregnancy – preterm birth, preeclampsia and fetal growth restriction. She is currently the Chief Investigator for the EPPI trial and the STRIDER NZAus trial. In addition to her role within the IMPACT Network, Katie is a Board member of PSANZ and ACTA and Chairperson of the Executive Committee for the ON TRACK New Zealand Maternal and Perinatal Health Clinical Trials National Network.

  • vicki flenady


    Associate Professor Vicki Flenady

    Associate Professor Vicki Flenady is currently Leader of the Stillbirth research program, Mothers and Babies Research Theme at the Mater Research Institute-University of Queensland. Vicki has a background in midwifery and neonatal nursing, has completed a Master’s degree in Medical Science (clinical epidemiology and biostatistics) and has a PhD and ongoing research interest is in the area of stillbirth prevention focusing on causes and risk factors and improving data collection. Vicki’s research interests also include preterm birth prevention which includes systematic reviews on the role of tocolytics for the Cochrane Pregnancy and Childbirth Group. Vicki currently Chairs the PSANZ IMPACT Network and is secretary of PSANZ SANDA.

  • frankbloomfield

    Professor Frank Bloomfield

    Professor Frank Bloomfield is Director of the Liggins Institute and Professor of Neonatology at the University of Auckland and consultant Neonatologist at National Women’s Health, Auckland City Hospital in Auckland, New Zealand. He is a member of the National Maternity Monitoring Group in NZ, the Governance Board of the National Intestinal Failure Service and a Council member of the Perinatal Research Society (USA). His research interests are in fetal and neonatal nutrition and how this impacts on growth, development and later risk of non-communicable disease and he is an active member of the Fetal and Neonatal Physiology sub-committee and the IMPACT Network for Mothers’ and Babies’ Health.

  • caroline crowther

    Professor Caroline Crowther

    Professor Caroline Crowther is a Maternal Fetal Medicine Subspecialist and Professor of Maternal and Perinatal Health at the Liggins Institute, University of Auckland with a conjoint position at The University of Adelaide. She has extensive experience in the design, conduct and analysis of randomized clinical trials and has coordinated many large, multicentre trials that focus on the evaluation of new maternal and perinatal therapies or care practices, in collaboration with researchers in key institutes in New Zealand, Australia and overseas. In 1995 she led the formation of the IMPACT Network and became the inaugural Chairperson.

  • maria makrides

    Professor Maria Makrides

    Professor Maria Makrides is Professor of Nutrition, The University of Adelaide and Theme Leader for Healthy Mothers, Babies and Children, South Australian Health and Medical Research Institute (SAHMRI) and leads the Child Nutrition Research Centre which is based at the Women’s and Children’s Hospital. As a research dietitian, Maria is committed to improving the nutrition and health of mothers and their babies through the conduct and translation of high quality research. She has over 200 peer reviewed publications including in the prestigious journals The Lancet, The Journal of the American Medical Association and the British Medical Journal. Maria’s group has conducted some of the key intervention trials involving omega-3 supplements in perinatal nutrition, and has recently been recognised with a National Health Medical Research Council (NHMRC) Centre for Research Excellence in Foods for Future Australians.

  • ben mol

    Professor Ben Mol

    Ben (Willem) Mol is Professor of Obstetrics and Gynaecology at the School of Paediatrics and Reproductive Health, The Robinson Institute, University of Adelaide. Ben studied Medicine at the University of Amsterdam, and trained in The Netherlands as clinical epidemiologist and obstetrician/gynaecologist. Ben holds an NHMRC practitioner fellowship. Ben was instrumental in initiating the Dutch consortium for Research in Women’s health, in which 70 hospitals collaborate in multicenter trials (www.studies-obsgyn.nl/). In 2010, he co-initiated the Global Obstetric Network GOnet. Ben considers his most important task to be the stimulation and innovation of evaluative research in Women’s health. His professional adage is ‘A day without randomisation is a day without progress.'

  • Profile jonathan morris

    Professor Jonathan Morris

    Professor Jonathan Morris is currently the Director of Research at the NSLHD and Kolling Institute which unites research and education with patient care and community wellbeing. He is a Maternal Fetal Medicine Specialist with an active clinical role in the management of women with high risk pregnancies. He directs a research group that extends from basic science to population health. He has led a number of large clinical trials and is an active member of IMPACT. He also has a keen interest in improving maternity and newborn care, health service efficiency and enabling research through the use of data. 

  • Image DrMartinKluckow

    Professor Martin Kluckow

    Professor Kluckow is a Senior Staff Specialist in Neonatology at Royal North Shore Hospital in Sydney and a Professor of Neonatology at the University of Sydney, Australia. He also holds an honorary position at 2 other academic hospitals.

    With his Sydney based research group, he has led the development of neonatal haemodynamics and point of care ultrasound in the neonatal unit for the past 20 years, publishing 86 peer reviewed articles. His research has centered around the physiology and transitional circulation of infants born prematurely, the time frame of changes and the relationship of these changes to complications of prematurity. He has particular interests in the patent ductus arteriosus, management of hypotension and pulmonary hypertension, umbilical cord clamping time and ultrasound training and accreditation.

    Professor Kluckow completed a PhD on the haemodynamic basis of intraventricular haemorrhage in preterm infants in 2000. His present research is now focusing on using some of the techniques developed, particularly point of care ultrasound at the bedside, to understand the physiology of transition and assess the effect of various interventions on prevention of brain injury in premature infants. Professor Kluckow has been involved in more than 10 multicentre collaborative clinical trials as a trial principal investigator or site chief investigator in the past 5 years.

    Professor Kluckow is the Australian and New Zealand Neonatal Network (ANZNN) representative on this subcommittee.


  • Professor William Tarnow-Mordi

    Professor of Neonatology, Westmead Clinical School, University of Sydney.

  • philippaMiddleton

    Associate Professor Philippa Middleton

    Associate Professor Philippa Middleton is a Principal Research Fellow with the Healthy Mothers, Babies and Children Theme of SAHMRI. She holds a NHMRC fellowship and is an affiliate with the Robinson Research Institute at the University of Adelaide. Philippa is a perinatal epidemiologist and implementation scientist with particular research interests in preterm birth, nutrition, stillbirth and diabetes in pregnancy. Philippa is a CI on the NHMRC funded My Babies Movements RCT and is involved in several Aboriginal health partnerships. She is an editor with the Cochrane Pregnancy and Childbirth Group and leads their Australian and New Zealand satellite.

  • lynn

    Dr Lynn Sinclair

    Dr Lynn Sinclair is a Clinical Nurse Consultant with the NSW Pregnancy and newborn Services Network (PSN) and an Associate of the Faculty of Health at the University of Technology, Sydney. She is the current Secretary and Neonatal Nursing Representative of the Perinatal Society of Australia and New Zealand (PSANZ) and an active member of several of the Society’s subcommittees. She is also a member of the Interdisciplinary Maternal Perinatal Australasian Collaborative Trials (IMPACT) Network’s steering and operational committees. Her current research interests include nursing knowledge and outcomes of neonatal care and improving parents’ understanding of extremely preterm infant outcome data.

  • Stefan Kane

    Dr Stefan Kane

    Stefan Kane MBBS BA BMedSc FRANZCOG DDU is a consultant obstetrician undertaking subspecialist training in maternal fetal medicine at the Royal Women's Hospital, Melbourne. He is also pursuing a PhD through the Department of Obstetrics and Gynaecology at the University of Melbourne, and to this end is undertaking a prospective observational study using Doppler interrogation of the maternal ophthalmic artery to assess cerebrovascular changes in pre-eclampsia. He acts as site co-ordinator for a range of multicentre trials, and is regularly involved in teaching and supervising medical students and doctors in training. In addition, Stefan contributes to the work of authorities responsible for the accreditation of prevocational medical training in Victoria and Queensland. He is married with four children.

  • hala work photo10

    Dr Hala Phipps

    Dr Hala Phipps has over 20 years experience in midwifery and has been actively involved in research for 16 years, culminating in the award of PhD in 2014. Hala has 18 original research articles published in peer reviewed journals and is a peer-reviewer for several midwifery and obstetric journals. She has a strong presence in the research and development team promoting translational research and innovation in health care. Currently Hala is actively researching methods of safely reducing the operative delivery rate in, relation to malposition in second stage of labour. As a midwife Hala is strongly committed to alleviating pain and discomfort for mother and baby.

  • Lucille Sebastian2

    Dr Lucille Sebastian

    Dr Lucille Sebastian is a program manager at the NHMRC Clinical Trials Centre, The University of Sydney. She has a background in physiology, biomarker research and clinical trial methodology. For the last 10 years, Lucille has managed oncology studies and neonatal trials (INIS, APTS and PAEAN). In 2016, Lucille became a member of the executive committee overseeing, implementing and guiding a novel program aiming to improve health outcomes for oncology patients by combining the latest innovations in clinical trial design with current advances in molecular biology. In her role, she works with academic and industry collaborators to expedite the translation of current and emerging evidence into practice.

  • Dr Carmel Collins

    Clinical Scientist, Senior Research Fellow, SAHMRI, Women's and Children's Hospital, Adelaide

  • vicbowring headshot LR 8593

    Victoria Bowring

    Victoria is the General Manager of the Stillbirth Foundation Australia - the only charity in Australia solely dedicated to research into causes, risk factors and prevention of stillbirth. She works closely with the Board of Directors to support the foundations research program and to encourage the engagement of parents and families in research education and advocacy. Victoria’s passion lies with ensuring the voices of the families experiencing stillbirth are heard and considered by the community, health departments and policy makers. Along with encouraging the joining of all organisations with an interest in stillbirth, to create a strong and united approach to reducing the incidence of stillbirth in Australia and providing the best possible care for those families affected by stillbirth.

  • Laura headshot

    Laura Mackay

    Laura Mackay is a Clinical Trial Manager in the Department of Obstetrics and Gynaecology at The University of Auckland, New Zealand. Laura has ten years’ experience in clinical trial coordination and management and is the Clinical Trial Manager for the STRIDER NZAus trial. Her current research focus is in supporting clinical trials aiming to prevent and treat the major complications of pregnancy.